BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1895101)

  • 1. Solubilized rat brain adenosine receptors have two high-affinity binding sites for 1,3-dipropyl-8-cyclopentylxanthine.
    Oliveira JC; Sebastião AM; Ribeiro JA
    J Neurochem; 1991 Oct; 57(4):1165-71. PubMed ID: 1895101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.
    Oliveira JC; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
    Smith AD; Cheek DJ; Buxton IL; Westfall DP
    Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T; Itahashi Y; Nomura Y
    J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.
    Peachey JA; Hourani SM; Kitchen I
    Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine.
    Weber RG; Jones CR; Lohse MJ; Palacios JM
    J Neurochem; 1990 Apr; 54(4):1344-53. PubMed ID: 2313291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium-dependent enhancement of endogenous agonist binding to A1 adenosine receptors: a complicating factor in quantitative autoradiography.
    Parkinson FE; Fredholm BB
    J Neurochem; 1992 Mar; 58(3):941-50. PubMed ID: 1738001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium.
    Musser B; Morgan ME; Leid M; Murray TF; Linden J; Vestal RE
    Eur J Pharmacol; 1993 Jul; 246(2):105-11. PubMed ID: 8397091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.
    Stiles GL
    J Neurochem; 1988 Nov; 51(5):1592-8. PubMed ID: 3139838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the solubilized A1 adenosine receptor from rat brain membranes.
    Klotz KN; Lohse MJ; Schwabe U
    J Neurochem; 1986 May; 46(5):1528-34. PubMed ID: 3007672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
    J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbate/Fe(3+)-induced peroxidation and inhibition of the binding of A1 adenosine receptor ligands in rat brain membranes.
    Oliveira JC; Constantino MD; Sebastião AM; Ribeiro JA
    Neurochem Int; 1995 Mar; 26(3):263-8. PubMed ID: 7787774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats.
    Matias A; Zimmer FJ; Lorenzen A; Keil R; Schwabe U
    Eur J Pharmacol; 1993 Feb; 244(3):223-30. PubMed ID: 8458399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain.
    Klotz KN; Keil R; Zimmer FJ; Schwabe U
    J Neurochem; 1990 Jun; 54(6):1988-94. PubMed ID: 2338552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P; Nordstedt C; Fredholm BB
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.
    Larrouy D; Galitzky J; Lafontan M
    Eur J Pharmacol; 1991 Feb; 206(2):139-47. PubMed ID: 2065717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the binding properties of A1 adenosine receptors in brain membranes of two congeneric marine fishes living at different depths.
    Murray TF; Siebenaller JF
    J Comp Physiol B; 1987; 157(3):267-77. PubMed ID: 3624581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histidine residues in agonist and antagonist binding sites of A1 adenosine receptor.
    Allende G; Casadó V; Mallol J; Franco R; Lluis C; Canela EI
    J Neurochem; 1993 Apr; 60(4):1525-33. PubMed ID: 8455039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.